Prognostic value of biological markers in myocardial infarction patients

Area of Science:

• Cardiology
• Biomarker Discovery
• Clinical Prognostics

Background:

• Q-wave myocardial infarction (MI) poses significant risks for fatal and nonfatal complications.
• Accurate prognostic markers are crucial for timely risk stratification and patient management.

Purpose of the Study:

• To compare the prognostic capabilities of matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-9 (MMP-9), and NT-pro-natriuretic peptide (NT-proBNP).
• To evaluate these biomarkers for predicting complications in acute and postinfarction periods for Q-wave MI patients.

Main Methods:

• A cohort of 85 patients with Q-wave MI was followed for one year post-hospitalization.
• Clinical endpoints were meticulously tracked via hospital systems and medical record reviews.
• Levels of MMP-3, MMP-9, and NT-proBNP were quantified using enzyme-linked immunosorbent assays.

Main Results:

• MMP-3 demonstrated high discriminatory power with a cutoff of 9.7 ng·mL⁻¹ (sensitivity 77.8%, specificity 90.8%).
• MMP-9 (cutoff 18.1 ng·mL⁻¹) and NT-proBNP (cutoff 885 pmol·L⁻¹) also showed prognostic value, though with lower specificity.
• MMP-3 and MMP-9 exhibited a strong positive prognostic association (70% prognostic value, 84% sensitivity, 82% specificity).

Conclusions:

• MMP-3 and MMP-9 are valuable biomarkers for predicting adverse outcomes in Q-wave MI patients.
• These findings can assist in refining cardiovascular mortality risk stratification for improved patient care.